Abstract

BackgroundThe increasing numbers of 3D compounds and protein complexes stored in databases contribute greatly to current advances in biotechnology, being employed in several pharmaceutical and industrial applications. However, screening and retrieving appropriate candidates as well as handling false positives presents a challenge for all post-screening analysis methods employed in retrieving therapeutic and industrial targets.ResultsUsing the TSCC method, virtually screened compounds were clustered based on their protein-ligand interactions, followed by structure clustering employing physicochemical features, to retrieve the final compounds. Based on the protein-ligand interaction profile (first stage), docked compounds can be clustered into groups with distinct binding interactions. Structure clustering (second stage) grouped similar compounds obtained from the first stage into clusters of similar structures; the lowest energy compound from each cluster being selected as a final candidate.ConclusionBy representing interactions at the atomic-level and including measures of interaction strength, better descriptions of protein-ligand interactions and a more specific analysis of virtual screening was achieved. The two-stage clustering approach enhanced our post-screening analysis resulting in accurate performances in clustering, mining and visualizing compound candidates, thus, improving virtual screening enrichment.

Highlights

  • The increasing numbers of 3D compounds and protein complexes stored in databases contribute greatly to current advances in biotechnology, being employed in several pharmaceutical and industrial applications

  • Since the above methods as well as Two-Stage Combinatorial Clustering (TSCC) encounter challenges of specific selectivity and false positives, we aim to provide advantages of our cluster analysis method to to enrich accuracy and effectively mine candidates for bioassay

  • VISCANA applies the ab initio fragment molecular orbital (FMO) method [14] to represent the interaction between a protein and its ligand

Read more

Summary

Introduction

The increasing numbers of 3D compounds and protein complexes stored in databases contribute greatly to current advances in biotechnology, being employed in several pharmaceutical and industrial applications. Screening and retrieving appropriate candidates as well as handling false positives presents a challenge for all post-screening analysis methods employed in retrieving therapeutic and industrial targets. Continuous advancements in high-throughput X-ray crystallography and genomics [1,2] account for numerous available three-dimensional (3D) structures, enabling the development of new potential therapeutic and industrial targets. The FMO method has an advantage of describing the charge-transfer between a receptor and a ligand in comparison to a conventional force field method using fixed atomic charges. It lacks sufficient descriptions of van der Waals forces and hydrogen bond interactions which play an important role in receptorligand binding and this may account for additional false positives

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call